Selected research
Industry Research
Biphasic Hyaluronic Acid Industry Research Report 2026
Market perspective
The global Biphasic Hyaluronic Acid market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Biphasic Hyaluronic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Biphasic Hyaluronic Acid is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Biphasic Hyaluronic Acid is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Biphasic Hyaluronic Acid include Humedix, Galderma, LG Corporation, Merz, Hugel, BioPlus, Teoxane, BioScience GmbH and NovaCutis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Biphasic Hyaluronic Acid market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biphasic Hyaluronic Acid Market by Company
Humedix
Galderma
LG Corporation
Merz
Hugel
BioPlus
Teoxane
BioScience GmbH
NovaCutis
Bohus Biotech AB
Allergan
Dr. Korman Laboratories
Haohai Biological Technology
Bloomage Biotechnology
IMEIK Technology Development
Huadong Medicine
Giant Biogene Holding
Jinbo Bio-Pharmaceutical
Trauer Biotechnology
SunMax Biotechnology
Biphasic Hyaluronic Acid Segment by Type
Injectable
Topical
Biphasic Hyaluronic Acid Segment by Application
Face
Hand
Earlobe
Lip
Others
Biphasic Hyaluronic Acid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biphasic Hyaluronic Acid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biphasic Hyaluronic Acid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biphasic Hyaluronic Acid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Biphasic Hyaluronic Acid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Biphasic Hyaluronic Acid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Biphasic Hyaluronic Acid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injectable
- Topical
Applications
- Face
- Hand
- Earlobe
- Lip
- Others
Companies covered
- Humedix
- Galderma
- LG Corporation
- Merz
- Hugel
- BioPlus
- Teoxane
- BioScience GmbH
- NovaCutis
- Bohus Biotech AB
- Allergan
- Dr. Korman Laboratories
- Haohai Biological Technology
- Bloomage Biotechnology
- IMEIK Technology Development
- Huadong Medicine
- Giant Biogene Holding
- Jinbo Bio-Pharmaceutical
- Trauer Biotechnology
- SunMax Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Biphasic Hyaluronic Acid Market Size (2021-2032)
- 2.2.2 Global Biphasic Hyaluronic Acid Sales (2021-2032)
- 2.2.3 Global Biphasic Hyaluronic Acid Market Average Price (2021-2032)
- 2.3 Biphasic Hyaluronic Acid by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injectable
- 2.3.3 Topical
- 2.4 Biphasic Hyaluronic Acid by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Face
- 2.4.3 Hand
- 2.4.4 Earlobe
- 2.4.5 Lip
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Biphasic Hyaluronic Acid Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Biphasic Hyaluronic Acid Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Biphasic Hyaluronic Acid Revenue of Manufacturers (2021-2026)
- 3.4 Global Biphasic Hyaluronic Acid Average Price by Manufacturers (2021-2026)
- 3.5 Global Biphasic Hyaluronic Acid Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Biphasic Hyaluronic Acid, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Biphasic Hyaluronic Acid, Product Type & Application
- 3.8 Global Manufacturers of Biphasic Hyaluronic Acid, Established Date
- 3.9 Global Biphasic Hyaluronic Acid Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Humedix
- 4.1.1 Humedix Company Information
- 4.1.2 Humedix Business Overview
- 4.1.3 Humedix Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Humedix Biphasic Hyaluronic Acid Product Portfolio
- 4.1.5 Humedix Recent Developments
- 4.2 Galderma
- 4.2.1 Galderma Company Information
- 4.2.2 Galderma Business Overview
- 4.2.3 Galderma Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Galderma Biphasic Hyaluronic Acid Product Portfolio
- 4.2.5 Galderma Recent Developments
- 4.3 LG Corporation
- 4.3.1 LG Corporation Company Information
- 4.3.2 LG Corporation Business Overview
- 4.3.3 LG Corporation Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 LG Corporation Biphasic Hyaluronic Acid Product Portfolio
- 4.3.5 LG Corporation Recent Developments
- 4.4 Merz
- 4.4.1 Merz Company Information
- 4.4.2 Merz Business Overview
- 4.4.3 Merz Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merz Biphasic Hyaluronic Acid Product Portfolio
- 4.4.5 Merz Recent Developments
- 4.5 Hugel
- 4.5.1 Hugel Company Information
- 4.5.2 Hugel Business Overview
- 4.5.3 Hugel Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hugel Biphasic Hyaluronic Acid Product Portfolio
- 4.5.5 Hugel Recent Developments
- 4.6 BioPlus
- 4.6.1 BioPlus Company Information
- 4.6.2 BioPlus Business Overview
- 4.6.3 BioPlus Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 BioPlus Biphasic Hyaluronic Acid Product Portfolio
- 4.6.5 BioPlus Recent Developments
- 4.7 Teoxane
- 4.7.1 Teoxane Company Information
- 4.7.2 Teoxane Business Overview
- 4.7.3 Teoxane Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Teoxane Biphasic Hyaluronic Acid Product Portfolio
- 4.7.5 Teoxane Recent Developments
- 4.8 BioScience GmbH
- 4.8.1 BioScience GmbH Company Information
- 4.8.2 BioScience GmbH Business Overview
- 4.8.3 BioScience GmbH Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 BioScience GmbH Biphasic Hyaluronic Acid Product Portfolio
- 4.8.5 BioScience GmbH Recent Developments
- 4.9 NovaCutis
- 4.9.1 NovaCutis Company Information
- 4.9.2 NovaCutis Business Overview
- 4.9.3 NovaCutis Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 NovaCutis Biphasic Hyaluronic Acid Product Portfolio
- 4.9.5 NovaCutis Recent Developments
- 4.10 Bohus Biotech AB
- 4.10.1 Bohus Biotech AB Company Information
- 4.10.2 Bohus Biotech AB Business Overview
- 4.10.3 Bohus Biotech AB Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bohus Biotech AB Biphasic Hyaluronic Acid Product Portfolio
- 4.10.5 Bohus Biotech AB Recent Developments
- 4.11 Allergan
- 4.11.1 Allergan Company Information
- 4.11.2 Allergan Business Overview
- 4.11.3 Allergan Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Allergan Biphasic Hyaluronic Acid Product Portfolio
- 4.11.5 Allergan Recent Developments
- 4.12 Dr. Korman Laboratories
- 4.12.1 Dr. Korman Laboratories Company Information
- 4.12.2 Dr. Korman Laboratories Business Overview
- 4.12.3 Dr. Korman Laboratories Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Dr. Korman Laboratories Biphasic Hyaluronic Acid Product Portfolio
- 4.12.5 Dr. Korman Laboratories Recent Developments
- 4.13 Haohai Biological Technology
- 4.13.1 Haohai Biological Technology Company Information
- 4.13.2 Haohai Biological Technology Business Overview
- 4.13.3 Haohai Biological Technology Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Haohai Biological Technology Biphasic Hyaluronic Acid Product Portfolio
- 4.13.5 Haohai Biological Technology Recent Developments
- 4.14 Bloomage Biotechnology
- 4.14.1 Bloomage Biotechnology Company Information
- 4.14.2 Bloomage Biotechnology Business Overview
- 4.14.3 Bloomage Biotechnology Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Bloomage Biotechnology Biphasic Hyaluronic Acid Product Portfolio
- 4.14.5 Bloomage Biotechnology Recent Developments
- 4.15 IMEIK Technology Development
- 4.15.1 IMEIK Technology Development Company Information
- 4.15.2 IMEIK Technology Development Business Overview
- 4.15.3 IMEIK Technology Development Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 IMEIK Technology Development Biphasic Hyaluronic Acid Product Portfolio
- 4.15.5 IMEIK Technology Development Recent Developments
- 4.16 Huadong Medicine
- 4.16.1 Huadong Medicine Company Information
- 4.16.2 Huadong Medicine Business Overview
- 4.16.3 Huadong Medicine Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Huadong Medicine Biphasic Hyaluronic Acid Product Portfolio
- 4.16.5 Huadong Medicine Recent Developments
- 4.17 Giant Biogene Holding
- 4.17.1 Giant Biogene Holding Company Information
- 4.17.2 Giant Biogene Holding Business Overview
- 4.17.3 Giant Biogene Holding Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Giant Biogene Holding Biphasic Hyaluronic Acid Product Portfolio
- 4.17.5 Giant Biogene Holding Recent Developments
- 4.18 Jinbo Bio-Pharmaceutical
- 4.18.1 Jinbo Bio-Pharmaceutical Company Information
- 4.18.2 Jinbo Bio-Pharmaceutical Business Overview
- 4.18.3 Jinbo Bio-Pharmaceutical Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Jinbo Bio-Pharmaceutical Biphasic Hyaluronic Acid Product Portfolio
- 4.18.5 Jinbo Bio-Pharmaceutical Recent Developments
- 4.19 Trauer Biotechnology
- 4.19.1 Trauer Biotechnology Company Information
- 4.19.2 Trauer Biotechnology Business Overview
- 4.19.3 Trauer Biotechnology Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Trauer Biotechnology Biphasic Hyaluronic Acid Product Portfolio
- 4.19.5 Trauer Biotechnology Recent Developments
- 4.20 SunMax Biotechnology
- 4.20.1 SunMax Biotechnology Company Information
- 4.20.2 SunMax Biotechnology Business Overview
- 4.20.3 SunMax Biotechnology Biphasic Hyaluronic Acid Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 SunMax Biotechnology Biphasic Hyaluronic Acid Product Portfolio
- 4.20.5 SunMax Biotechnology Recent Developments
5 Global Biphasic Hyaluronic Acid Market Scenario by Region
- 5.1 Global Biphasic Hyaluronic Acid Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Biphasic Hyaluronic Acid Sales by Region: 2021-2032
- 5.2.1 Global Biphasic Hyaluronic Acid Sales by Region: 2021-2026
- 5.2.2 Global Biphasic Hyaluronic Acid Sales by Region: 2027-2032
- 5.3 Global Biphasic Hyaluronic Acid Revenue by Region: 2021-2032
- 5.3.1 Global Biphasic Hyaluronic Acid Revenue by Region: 2021-2026
- 5.3.2 Global Biphasic Hyaluronic Acid Revenue by Region: 2027-2032
- 5.4 North America Biphasic Hyaluronic Acid Market Facts & Figures by Country
- 5.4.1 North America Biphasic Hyaluronic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Biphasic Hyaluronic Acid Sales by Country (2021-2032)
- 5.4.3 North America Biphasic Hyaluronic Acid Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Biphasic Hyaluronic Acid Market Facts & Figures by Country
- 5.5.1 Europe Biphasic Hyaluronic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Biphasic Hyaluronic Acid Sales by Country (2021-2032)
- 5.5.3 Europe Biphasic Hyaluronic Acid Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Biphasic Hyaluronic Acid Market Facts & Figures by Country
- 5.6.1 Asia Pacific Biphasic Hyaluronic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Biphasic Hyaluronic Acid Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Biphasic Hyaluronic Acid Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Biphasic Hyaluronic Acid Market Facts & Figures by Country
- 5.7.1 South America Biphasic Hyaluronic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Biphasic Hyaluronic Acid Sales by Country (2021-2032)
- 5.7.3 South America Biphasic Hyaluronic Acid Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Biphasic Hyaluronic Acid Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Biphasic Hyaluronic Acid Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Biphasic Hyaluronic Acid Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Biphasic Hyaluronic Acid Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Biphasic Hyaluronic Acid Sales by Type (2021-2032)
- 6.1.1 Global Biphasic Hyaluronic Acid Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Biphasic Hyaluronic Acid Sales Market Share by Type (2021-2032)
- 6.2 Global Biphasic Hyaluronic Acid Revenue by Type (2021-2032)
- 6.2.1 Global Biphasic Hyaluronic Acid Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Biphasic Hyaluronic Acid Revenue Market Share by Type (2021-2032)
- 6.3 Global Biphasic Hyaluronic Acid Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Biphasic Hyaluronic Acid Sales by Application (2021-2032)
- 7.1.1 Global Biphasic Hyaluronic Acid Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Biphasic Hyaluronic Acid Sales Market Share by Application (2021-2032)
- 7.2 Global Biphasic Hyaluronic Acid Revenue by Application (2021-2032)
- 7.2.1 Global Biphasic Hyaluronic Acid Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Biphasic Hyaluronic Acid Revenue Market Share by Application (2021-2032)
- 7.3 Global Biphasic Hyaluronic Acid Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Biphasic Hyaluronic Acid Value Chain Analysis
- 8.1.1 Biphasic Hyaluronic Acid Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Biphasic Hyaluronic Acid Production Mode & Process
- 8.2 Biphasic Hyaluronic Acid Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Biphasic Hyaluronic Acid Distributors
- 8.2.3 Biphasic Hyaluronic Acid Customers
9 Global Biphasic Hyaluronic Acid Analyzing Market Dynamics
- 9.1 Biphasic Hyaluronic Acid Industry Trends
- 9.2 Biphasic Hyaluronic Acid Industry Drivers
- 9.3 Biphasic Hyaluronic Acid Industry Opportunities and Challenges
- 9.4 Biphasic Hyaluronic Acid Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst